Jiangsu Hengrui Pharmaceuticals Aktie
Bilanz/GuV
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| EBITDA in Mio. | |||||
| EBITDA in Mio. | 4.604 € | 4.553 € | 5.378 € | 7.951 € | 9.567 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 2.087 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | 2.976 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | 2.298 € |
| Operatives Ergebnis (EBIT) in Mio. | |||||
| Operatives Ergebnis (EBIT) in Mio. | 4.084 € | 3.975 € | 4.673 € | 7.175 € | 8.722 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 2.087 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 2.140 € | 2.976 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 1.291 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 1.881 € | 2.298 € |
| Finanzergebnis in Mio. | |||||
| Finanzergebnis in Mio. | 21.822 € | 17.931 € | 18.194 € | 21.181 € | 23.033 € |
| Ergebnis vor Steuern (EBT) in Mio. | |||||
| Ergebnis vor Steuern (EBT) in Mio. | 4.466 € | 3.968 € | 4.667 € | 7.170 € | 8.708 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 2.076 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 2.249 € | 2.975 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 1.335 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 2.083 € | 2.296 € |
| Steuern auf Einkommen und Ertrag in Mio. | |||||
| Steuern auf Einkommen und Ertrag in Mio. | -18 € | 153 € | 389 € | 833 € | 991 € |
| Ergebnis nach Steuer in Mio. | |||||
| Ergebnis nach Steuer in Mio. | 4.530 € | 3.906 € | 4.302 € | 6.337 € | 7.711 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 1.874 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 2.063 € | 2.576 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 1.188 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 1.717 € | 1.960 € |
| Nettogewinn/-verlust in Mio. | |||||
| Nettogewinn/-verlust in Mio. | - | - | - | - | - |
Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Umlaufvermögen in Mio. | |||||
| Umlaufvermögen in Mio. | 30.188 € | 30.934 € | 31.287 € | 35.315 € | 51.490 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 35.970 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 34.777 € | 46.760 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 34.457 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 35.315 € | 51.490 € |
| Anlagevermögen in Mio. | |||||
| Anlagevermögen in Mio. | 9.078 € | 11.437 € | 12.497 € | 14.821 € | 18.377 € |
| Aktiva in Mio. | |||||
| Aktiva in Mio. | 39.266 € | 42.371 € | 43.785 € | 50.136 € | 69.867 € |
Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| kurzfristiges Fremdkapital in Mio. | |||||
| kurzfristiges Fremdkapital in Mio. | 3.402 € | 3.639 € | 2.554 € | 3.634 € | 6.369 € |
| langfristiges Fremdkapital in Mio. | |||||
| langfristiges Fremdkapital in Mio. | 293 € | 319 € | 198 € | 412 € | 1.701 € |
| Fremdkapital in Mio. | |||||
| Fremdkapital in Mio. | 3.694 € | 3.958 € | 2.751 € | 4.045 € | 8.070 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 3.743 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 4.994 € | 3.864 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 4.007 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 4.045 € | 8.070 € |
| Minderheitenanteil in Mio. | |||||
| Minderheitenanteil in Mio. | 0 € | 589 € | 567 € | 570 € | 525 € |
| Eigenkapital in Mio. | |||||
| Eigenkapital in Mio. | 35.003 € | 37.824 € | 40.466 € | 45.520 € | 61.272 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 46.987 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 42.622 € | 58.465 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 43.768 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 45.520 € | 61.272 € |
| Passiva in Mio. | |||||
| Passiva in Mio. | 39.266 € | 42.371 € | 43.785 € | 50.136 € | 69.867 € |
Quelle: Leeway